Oxidative stress in aging-matters of the heart and mind

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 17897-17925

  Venkataraman, Krishnan ^a   Khurana, Sandhya ^b   Tai, T C ^b,c  

^a Huntington University   (Canada)

^b NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^c LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Aging; Brain; Cardiovascular; Oxidative stress; RONS

Indexed keywords

ATORVASTATIN; BETA ADRENERGIC RECEPTOR; CYTOCHROME C; FREE RADICAL; HYDROGEN PEROXIDE; ISOPRENALINE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

AGED; AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BRAIN DAMAGE; BRAIN ISCHEMIA; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL PROTECTION; CENTRAL NERVOUS SYSTEM DISEASE; CYTOPLASM; ENDOTHELIAL DYSFUNCTION; ENZYME RELEASE; EVOLUTIONARY ADAPTATION; GENETIC REGULATION; GERIATRIC DISORDER; HEART FUNCTION; HEART HYPERTROPHY; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRION; MOLECULAR PATHOLOGY; NEUROANATOMY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

AGING; ANIMALS; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84883616680     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140917897     Document Type: Review

References (164)

1. Yu, B.P.; Yang, R. Critical evaluation of the free radical theory of aging a proposal for the oxidative stress hypothesis. Ann. N. Y. Acad. Sci. 1996, 785, 1-11.
2. Schoneich, C. Reactive oxygen species and biological aging: A mechanistic approach. Exp. Gerontol. 1999, 34, 19-34.
3. Jacob, K.D.; Noren Hooten, N.; Trzeciak, A.R.; Evans, M.K. Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech. Ageing Dev. 2013, 134, 139-157.
4. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44, 129-146.
5. Sahin, E.; Depinho, R.A. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010, 464, 520-528.
6. Moller, P.; Lohr, M.; Folkmann, J.K.; Mikkelsen, L.; Loft, S. Aging and oxidatively damaged nuclear DNA in animal organs. Free Radic. Biol. Med. 2010, 48, 1275-1285.
7. Harman, D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11, 298-300.
8. Giustarini, D.; Dalle-Donne, I.; Tsikas, D.; Rossi, R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Cri. Rev. Clin. Lab. Sci. 2009, 46, 241-281.
9. Rosenfeldt, F.; Wilson, M.; Lee, G.; Kure, C.; Ou, R.; Braun, L.; de Haan, J. Oxidative stress in surgery in an ageing population: Pathophysiology and therapy. Exp. Gerontol. 2013, 48, 45-54.
10. Sies, H. Oxidantive stress: Oxidants and antioxidants. Exp. Physiol. 1997, 82, 292-295.
11. Prince, M.; Bryce, R.; Albanese, E.; Wimo, A.; Ribeiro, W.; Ferri, C.P. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013, 9, 63-75.
12. Karavidas, A.; Lazaros G.; Tsiachris, D.; Pyrgakis, V. Aging and the cardiovascular system. Hell. J. Cardiol. 2010, 51, 421-427.
13. Raina, P.S.; Wolfson, C.; Kirkland, S.A.; Griffith, L.E.; Oremus, M.; Patterson, C.; Tuokko, H.; Penning, M.; Balion, C.M.; Hogan, D.; et al. The Canadian longitudinal study on aging (CLSA). Can. J. Aging 2009, 28, 221-229.
14. Muqtadar, H.; Testai, F.D.; Gorelick, P.B. The dementia of cardiac disease. Curr. Cardiol. Rep. 2012, 14, 732-740.
15. Newman, A.B.; Fitzpatrick, A.L.; Lopez, O.; Jackson, S.; Lyketsos, C.; Jagust, W.; Ives, D.; Dekosky, S.T.; Kuller, L.H. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J. Am. Geriatr. Soc. 2005, 53, 1101-1107.
16. Matsuzaki, S.; Szweda, P.A.; Szweda, L.I.; Humphries, K.M. Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning. Adv. Drug Deliv. Rev. 2009, 61, 1324-1331.
17. Castro, L.; Demicheli, V.; Tortora, V.; Radi, R. Mitochondrial protein tyrosine nitration. Free Radic. Res. 2011, 45, 37-52.
18. Pollack, M.; Leeuwenburgh, C. Molecular Mechanisms of Oxidative Stress in Aging: Free Radicals, Aging, Antioxidants and Disease. In Handbook of Oxidants and Antioxidants in Exercise; Elsevier Science Publishers: Amsterdam, The Netherlands, 1999; pp. 881-923.
19. Sohal, R.; Orr, W. The redox stress hypothesis of aging. Free Radic. Bio. Med. 2012, 52, 539-555.
20. Drummond, G.; Selemidis, S. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 2011, 10, 453-471.
21. Yu, B.P.; Chung, H.Y. Oxidative stress and vascular aging. Diabetes Res. Clin. Pract. 2001, 54, S73-S80.
22. Eiserich, J.P.; Patel, R.P.; O'Donnell, V.B. Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules. Mol. Asp. Med. 1999, 19, 221-357.
23. Paravicini, T.M.; Touyz, R.M. NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care 2008, 31, S170-S180.
24. Lacy, F.; Gough, D.A.; Schmid-Schonbein, G.W. Role of xanthine oxidase in hydrogen peroxide production. Free Radic. Bio. Med. 1998, 25, 720-727.
25. Catala, A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 2009, 157, 1-11.
26. Vallyathan, V.; Shi, X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 1997, 105, S165-S177.
27. Dizdaroglu, M. Oxidatively induced DNA damage: Mechanisms, repair and disease. Cancer Lett. 2012, 327, 26-47.
28. Shan, X.; Lin, C.-L.G. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging 2006, 27, 657-662.
29. Zhang, J.; Perry, G.; Smith, M.A.; Robertson, D.; Olson, S.J.; Graham, D.G.; Montine, T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 1999, 154, 1423-1429.
30. Widmer, R.; Ziaja, I.; Grune, T. Protein oxidation and degradation during aging: Role in skin aging and neurodegeneration. Free Radic. Res. 2006, 40, 1259-1268.
31. Jung, T.; Catalgol, B.; Grune, T. The proteasomal system. Mol. Asp. Med. 2009, 30, 191-296.
32. Orlandi, A.; Bochaton-Piallat, M.-L.; Gabbiani, G.; Spagnoli, L.G. Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis. Atherosclerosis 2006, 188, 221-230.
33. De la Haba, C.; Palacio, J.R.; Martinez, P.; Morros, A. Effect of oxidative stress on plasma membrane fluidity of THP-1 induced macrophages. Biochim. Biophys. Acta 2013, 1828, 357-364.
34. Freikman, I.; Amer, J.; Cohen, J.S.; Ringel, I.; Fibach, E. Oxidative stress causes membrane phospholipid rearrangement and shedding from RBC membranes-An NMR study. Biochim. Biophys. Acta 2008, 1778, 2388-2394.
35. Clement, A.B.; Gimpl, G.; Behl, C. Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein. Free Radic. Biol. Med. 2010, 48, 1236-1241.
36. Saxena, S.; Srivastava, P.; Kumar, D.; Khanna, V.K.; Seth, P.K. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease. Ocul. Immunol. Inflamm. 2006, 14, 113-116.
37. Johnson, P. Antioxidant enzyme expression in health and disease: Effects of exercise and hypertension. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2002, 133, 493-505.
38. Das, M.; Babu, K.; Reddy, N.P.; Srivastava, L.M. Oxidative damage of plasma proteins and lipids in epidemic dropsy patients: Alterations in antioxidant status. Biochim. Biophys. Acta 2005, 1722, 209-217.
39. Harper, M.E.; Bevilacqua, L.; Hagopian, K.; Weindruch, R.; Ramsey, J.J. Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiol. Scand. 2004, 182, 321-331.
40. Echtay, K.S.; Roussel, D.; St-Pierre, J.; Jekabsons, M.B.; Cadenas, S.; Stuart, J.A.; Harper, J.A.; Roebuck, S.J.; Morrison, A.; Pickering, S.; et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415, 96-99.
41. Webb, R.C.; Inscho, E.W. Age-Related Changes in the Cardiovascular System. In Clinical Hypertension and Vascular Diseases: Hypertension in the Elderly; Humana Press Inc: Toyowa, NJ, USA, 2005; pp. 11-21.
42. Oxenham, H.; Sharpe, N. Cardiovascular aging and heart failure. Eur. J. Heart Fail. 2003, 5, 427-434.
43. Benjamin, E.; Plehn, J. Mitral annular calcification and the risk of stroke in an elderly cohort. N. Engl. J. Med. 1992, 327, 374-379.
44. Dai, D.F.; Rabinovitch, P.S.; Ungvari, Z. Mitochondria and cardiovascular aging. Cardiocirc. Res. 2012, 110, 1109-1124.
45. Navarro, A.; Boveris, A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292, C670-C686.
46. Herrera, M.D.; Mingorance, C.; Rodriguez-Rodriguez, R.; Alvarez de Sotomayor, M. Endothelial dysfunction and aging: An update. Ageing Res. Rev. 2010, 9, 142-152.
47. Pierce, G.L.; Larocca, T.J. Reduced vascular tetrahydrobiopterin (BH4) and endothelial function with ageing: Is it time for a chronic BH4 supplementation trial in middle-aged and older adults? J. Physiol. 2008, 586, 2673-2674.
48. Bode-Boger, S.M.; Scalera, F.; Ignarro, L.J. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol. Ther. 2007, 114, 295-306.
49. Yang, Z.; Ming, X.-F. Arginase: The emerging therapeutic target for vascular oxidative stress and inflammation. Front. Immunol. 2013, 4, 149.
50. Kim, J.H.; Bugaj, L.J.; Oh, Y.J.; Bivalacqua, T.J.; Ryoo, S.; Soucy, K.G.; Santhanam, L.; Webb, A.; Camara, A.; Sikka, G.; et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 2009, 107, 1249-57.
51. Bode-Boger, S.M.; Muke, J.; Surdacki, A.; Brabant, G.; Boger, R.H.; Frolich, J.C. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 2003, 8, 77-81.
52. Susic, D.; Varagic, J.; Frohlich, E.D. Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition. Hypertension 2001, 38, 1422-1426.
53. Susic, D.; Francischetti, A.; Frohlich, E.D. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension 1999, 33, 451-455.
54. Qian, H.; Luo, N.; Chi, Y. Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders. J. Aging Res. 2012, doi:10.1155/2012/121390.
55. Singh, N.; Prasad, S.; Singer, D.R.; MacAllister, R.J. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin. Sci. 2002, 102, 595-600.
56. Li, N.; Karin, M. Is NF-κB the sensor of oxidative stress? FASEB J. 1999, 13, 1137-1143.
57. Csiszar, A.; Ungvari, Z.; Koller, A.; Edwards, J.G.; Kaley, G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 2003, 17, 1183-1185.
58. Bruunsgaard, H.; Skinhoj, P.; Pedersen, A.N.; Schroll, M.; Pedersen, B.K. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol. 2000, 121, 255-260.
59. Belmin, J.; Bernard, C.; Corman, B.; Merval, R.; Esposito, B.; Tedgui, A. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am. J. Physiol. Heart Circ. Physiol. 1995, 268, H2288-H2293.
60. Csiszar, A.; Wang, M.; Lakatta, E.G.; Ungvari, Z. Inflammation and endothelial dysfunction during aging: Role of NF-kappaB. J. Appl. Physiol. 2008, 105, 1333-1341.
61. Donato, A.J.; Eskurza, I.; Silver, A.E.; Levy, A.S.; Pierce, G.L.; Gates, P.E.; Seals, D.R. Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Cardiocirc. Res. 2007, 100, 1659-1666.
62. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83, 456S-460S.
63. Marui, N.; Offermann, M.K.; Swerlick, R.; Kunsch, C.; Rosen, C.A.; Ahmad, M.; Alexander, R.W.; Medford, R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 1993, 92, 1866-1874.
64. Hansson, G.K.; Libby, P. The immune response in atherosclerosis: A double-edged sword. Nat. Rev. Immunol. 2006, 6, 508-519.
65. Richter, V.; Rassoul, F.; Purschwitz, K.; Hentschel, B.; Reuter, W.; Kuntze, T. Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 2003, 49, 293-300.
66. Morisaki, N.; Saito, I.; Tamura, K.; Tashiro, J.; Masuda, M.; Kanzaki, T.; Watanabe, S.; Masuda, Y.; Saito, Y. New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997, 131, 43-48.
67. Schmidt, A.M.; Hori, O.; Chen, J.X.; Li, J.F.; Crandall, J.; Zhang, J.; Cao, R.; Yan, S.D.; Brett, J.; Stern, D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 1995, 96, 1395-1403.
68. Wang, M.; Takagi, G.; Asai, K.; Resuello, R.G.; Natividad, F.F.; Vatner, D.E.; Vatner, S.F.; Lakatta, E.G. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003, 41, 1308-1316.
69. Yamamoto, K.; Takeshita, K.; Kojima, T.; Takamatsu, J.; Saito, H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: Implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc. Res. 2005, 66, 276-285.
70. Yamamoto, K.; Takeshita, K.; Shimokawa, T.; Yi, H.; Isobe, K.; Loskutoff, D.J.; Saito, H. Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals. Proc. Natl. Acad. Sci. USA 2002, 99, 890-895.
71. Chung, H.; Sung, B.; Jung, K. The molecular inflammatory process in aging. Antioxid. Redox Sign. 2006, 8, 572-581.
72. Cernadas, M.R.; de Miguel, L.S.; Garcia-Duran, M.; Gonzalez-Fernandez, F.; Millas, I.; Monton, M.; Rodrigo, J.; Rico, L.; Fernandez, P.; de Frutos, T.; et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Cardiocirc. Res. 1998, 83, 279-286.
73. Li, D.; Qu, Y.; Tao, L.; Liu, H.; Hu, A.; Gao, F.; Sharifi-Azad, S.; Grunwald, Z.; Ma, X.L.; Sun, J.Z. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial. J. Surg. Res. 2006, 72, 64-72.
74. Hayashi, T.; Yano, K.; Matsui-Hirai, H.; Yokoo, H.; Hattori, Y.; Iguchi, A. Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 2008, 120, 333-339.
75. Von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27, 339-344.
76. Chung, J.H.; Seo, A.Y.; Chung, S.W.; Kim, M.K.; Leeuwenburgh, C.; Yu, B.P.; Chung, H.Y. Molecular mechanism of PPAR in the regulation of age-related inflammation. Ageing Res. Rev. 2008, 7, 126-136.
77. Delerive, P.; de Bosscher, K.; Besnard, S.; vanden Berghe, W.; Peters, J.M.; Gonzalez, F.J.; Fruchart, J.C.; Tedgui, A.; Haegeman, G.; Staels, B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappa B and AP-1. J. Biol. Chem. 1999, 274, 32048-32054.
78. Sung, B.; Park, S.; Yu, B.P.; Chung, H.Y. Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: Suppression of NF-kappaB by 2,4-thiazolidinedione. Exp. Gerontol. 2006, 41, 590-599.
79. Han, L.; Li, M.; Liu, Y.; Han, C.; Ye, P. Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats. Pharmacology 2012, 89, 74-82.
80. Sung, B.; Park, S.; Yu, B.P.; Chung, H.Y. Modulation of PPAR in aging, inflammation, and calorie restriction. J. Gerontol. Ser. A 2004, 59, B997-B1006.
81. Chung, H.Y.; Cesari, M.; Anton, S.; Marzetti, E.; Giovannini, S.; Seo, A.Y.; Carter, C.; Yu, B.P.; Leeuwenburgh, C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8, 18-30.
82. Rippe, C.; Lesniewski, L.; Connell, M.; LaRocca, T.; Donato, A.; Seals, D. Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging cell 2010, 9, 304-312.
83. Csiszar, A.; Labinskyy, N.; Jimenez, R.; Pinto, J.T.; Ballabh, P.; Losonczy, G.; Pearson, K.J.; de Cabo, R.; Ungvari, Z. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1. Mech. Ageing Dev. 2009, 130, 518-527.
84. Fusco, S.; Maulucci, G.; Pani, G. Sirt1: Def-eating senescence? Cell Cycle 2012, 11, 4135-4146.
85. Dai, D.F.; Chen, T.; Johnson, S.C.; Szeto, H.; Rabinovitch, P.S. Cardiac aging: From molecular mechanisms to significance in human health and disease. Antioxid. Redox Sign. 2012, 16, 1492-1526.
86. Eggers, K.M.; Lind, L.; Ahlstrom, H.; Bjerner, T.; Ebeling Barbier, C.; Larsson, A.; Venge, P.; Lindahl, B. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur. Heart J. 2008, 29, 2252-2258.
87. De Lemos, J.A.; Drazner, M.H.; Omland, T.; Ayers, C.R.; Khera, A.; Rohatgi, A.; Hashim, I.; Berry, J.D.; Das, S.R.; Morrow, D.A.; et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304, 2503-2512.
88. Wu, A.H.; Ford, L. Release of cardiac troponin in acute coronary syndromes: Ischemia or necrosis? Clin. Chim. Acta 1999, 284, 161-174.
89. Centurione, L.; Antonucci, A.; Miscia, S.; Grilli, A.; Rapino, M.; Grifone, G.; di Giacomo, V.; di Giulio, C.; Falconi, M.; Cataldi, A. Age-related death-survival balance in myocardium: An immunohistochemical and biochemical study. Mech. Ageing Dev. 2002, 123, 341-350.
90. Bodyak, N.; Kang, P. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res. 2002, 30, 3788-3794.
91. Li, S.Y.; Du, M.; Dolence, E.K.; Fang, C.X.; Mayer, G.E.; Ceylan-Isik, A.F.; LaCour, K.H.; Yang, X.; Wilbert, C.J.; Sreejayan, N.; et al. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 2005, 4, 57-64.
92. Hegab, Z.; Gibbons, S.; Neyses, L.; Mamas, A. Role of advanced glycation end products in cardiovascular disease. World J. Cardiol. 2012, 4, 90-102.
93. Essick, E.E.; Sam, F. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid. Med. Cell. Longev. 2010, 3, 168-177.
94. Chiong, M.; Wang, Z.V.; Pedrozo, Z.; Cao, D.J.; Troncoso, R.; Ibacache, M.; Criollo, A.; Nemchenko, A.; Hill, J.A.; Lavandero, S. Cardiomyocyte death: Mechanisms and translational implications. Cell Death Dis. 2011, 2, e244.
95. Peng, L.; Zhuang, X.; Liao, L.; He, X.; Li, J.; Chen, X.; Lu, G.; Ma, H.; Gao, X. Changes in cell autophagy and apoptosis during age-related left ventricular remodeling in mice and their potential mechanisms. Biochem. Biophys. Res. Commun. 2013, 430, 822-826.
96. Wohlgemuth, S.E.; Julian, D.; Akin, D.E.; Fried, J.; Toscano, K.; Leeuwenburgh, C.; Dunn, W.A. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res. 2007, 10, 281-292.
97. Niemann, B.; Chen, Y.; Issa, H.; Silber, R.E.; Rohrbach, S. Caloric restriction delays cardiac ageing in rats: Role of mitochondria. Cardiovasc. Res. 2010, 88, 267-276.
98. Lee, C.K.; Pugh, T.D.; Klopp, R.G.; Edwards, J.; Allison, D.B.; Weindruch, R.; Prolla, T.A. The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Free Radic. Bio. Med. 2004, 36, 1043-1057.
99. Lee, C.K.; Allison, D.B.; Brand, J.; Weindruch, R.; Prolla, T.A. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc. Natl. Acad. Sci. USA 2002, 99, 14988-14993.
100. Park, S.K.; Prolla, T.A. Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc. Res. 2005, 66, 205-212.
101. Ren, J.; Pulakat, L.; Whaley-Connell, A.; Sowers, J.R. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. 2010, 88, 993-1001.
102. Lesnefsky, E.J.; Moghaddas, S.; Tandler, B.; Kerner, J.; Hoppel, C.L. Mitochondrial dysfunction in cardiac disease: Ischemia-Reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 2001, 33, 1065-1089.
103. Turdi, S.; Fan, X.; Li, J.; Zhao, J.; Huff, A.F.; Du, M.; Ren, J. AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging cell 2010, 9, 592-606.
104. Dillon, L.M.; Rebelo, A.P.; Moraes, C.T. The role of PGC-1 coactivators in aging skeletal muscle and heart. IUBMB Life 2012, 64, 231-241.
105. Wojtovich, A.P.; Nadtochiy, S.M.; Brookes, P.S.; Nehrke, K. Ischemic preconditioning: The role of mitochondria and aging. Exp. Gerontol. 2012, 47, 1-7.
106. Lucas, D.T.; Szweda, L.I. Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA 1998, 95, 510-514.
107. Liu, M.; Zhang, P.; Chen, M.; Zhang, W.; Yu, L.; Yang, X.C.; Fan, Q. Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats. Age 2012, 34, 621-632.
108. Simkhovich, B.Z.; Marjoram, P.; Poizat, C.; Kedes, L.; Kloner, R.A. Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch. Biochem. Biophys. 2003, 420, 268-278.
109. Abete, P.; Testa, G.; Cacciatore, F.; Della-Morte, D.; Galizia, G.; Langellotto, A.; Rengo, F. Ischemic preconditioning in the younger and aged heart. Aging Dis. 2011, 2, 138-148.
110. Benigni, A.; Cassis, P.; Remuzzi, G. Angiotensin II revisited: New roles in inflammation, immunology and aging. EMBO Mol. Med. 2010, 2, 247-257.
111. Baylis, C.; Engels, K.; Hymel, A.; Navar, L. Plasma renin activity and metabolic clearance rate of angiotensin II in the unstressed aging rat. Mech. Ageing Dev. 1997, 97, 163-171.
112. Thompson, M.; Oyama, T. Activity and responsiveness of the renin-angiotensin system in the aging rat. Am. J. Physiol. 2000, 279, R1787-R1794.
113. Nguyen Dinh Cat, A.; Touyz, R.M. A new look at the renin-angiotensin system-Focusing on the vascular system. Peptides 2011, 32, 2141-2150.
114. Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B.A.; Griendling, K.K.; Harrison, D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Investig. 1996, 97, 1916-1923.
115. Williams, B. Angiotensin II and the pathophysiology of cardiovascular remodeling. Am. J. Cardiol. 2001, 87, 10-17.
116. Mohamed, M.A.; Weir, M.R. Renin angiotensin system inhibition in the older person: A review. Clin. Geriatr. Med. 2009, 25, 245-257.
117. Benigni, A.; Corna, D.; Zoja, C. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 2009, 119, 524-530.
118. De Cavanagh, E.M.V.; Inserra, F.; Ferder, L. Angiotensin II blockade: A strategy to slow ageing by protecting mitochondria? Cardiovasc. Res. 2011, 89, 31-40.
119. Jia, L.; Li, Y.; Xiao, C.; Du, J. Angiotensin II induces inflammation leading to cardiac remodeling. Front. Biosci. 2012, 1, 221-231.
120. Santulli, G.; Iaccarino, G. Pinpointing beta adrenergic receptor in ageing pathophysiology: Victim or executioner? Evidence from crime scenes Pinpointing beta adrenergic receptor in ageing pathophysiology: Victim or executioner? Evidence from crime scenes. Immun. Ageing 2013, doi:10.1186/1742-4933-10-10.
121. Kang, K.B.; Rajanayagam, M.A.S.; van der Zypp, A.; Majewski, H. A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 375, 273-281.
122. Yan, L.; Vatner, D.E.; O'Connor, J.P.; Ivessa, A.; Ge, H.; Chen, W.; Hirotani, S.; Ishikawa, Y.; Sadoshima, J.; Vatner, S.F. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007, 130, 247-258.
123. Okumura, S.; Vatner, D.E.; Kurotani, R.; Bai, Y.; Gao, S.; Yuan, Z.; Iwatsubo, K.; Ulucan, C.; Kawabe, J.; Ghosh, K.; et al. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation 2007, 116, 1776-1783.
124. Remondino, A. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Cardiocirc. Res. 2003, 92, 136-138.
125. Bishop, N.A.; Lu, T.; Yankner, B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464, 529-535.
126. Mariani, E.; Polidori, M.C.; Cherubini, A.; Mecocci, P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J. Chromatogr. B 2005, 827, 65-75.
127. Freeman, L.R.; Keller, J.N. Oxidative stress and cerebral endothelial cells: Regulation of the blood-brain-barrier and antioxidant based interventions. Biochim. Biophys. Acta 2012, 1822, 822-829.
128. Alikunju, S.; Abdul Muneer, P.M.; Zhang, Y.; Szlachetka, A.M.; Haorah, J. The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components. Brain Behav. Immun. 2011, 25, S129-S136.
129. Perfeito, R.; Cunha-Oliveira, T.; Rego, A.C. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-Resemblance to the effect of amphetamine drugs of abuse. Free Radic. Bio. Med. 2012, 53, 1791-1806.
130. Chen, C.M.; Liu, J.L.; Wu, Y.R.; Chen, Y.C.; Cheng, H.S.; Cheng, M.L.; Chiu, D.T.Y. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiol. Dis. 2009, 33, 429-435.
131. Rogakou, E.P.; Boon, C.; Redon, C.; Bonner, W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 1999, 146, 905-916.
132. Pandey, K.B.; Rizvi, S.I. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid. Med. Cell. Longev. 2010, 3, 2-12.
133. Milne, G.L.; Sanchez, S.C.; Musiek, E.S.; Morrow, J.D. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2007, 2, 221-226.
134. Smith, C.D. Structural imaging in early pre-states of dementia. Biochim. Biophys. Acta 2012, 1822, 317-324.
135. Morley, J.E.; Armbrecht, H.J.; Farr, S.A.; Kumar, V.B. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim. Biophys. Acta 2012, 1822, 650-656.
136. Medeiros, R.; Baglietto-Vargas, D.; LaFerla, F.M. The role of tau in Alzheimer's disease and related disorders. CNS Neurosci. Ther. 2011, 17, 514-524.
137. Jack, C.R., Jr.; Garwood, M.; Wengenack, T.M.; Curran, G.L.; Lin, J.; Adriany, G.; Grohn, H.J.; Grimm, R.; Poduslo, J.F. In vivo visualization of Alzheimer's amyloid paques by MRI in transgenic mice without a contrast agent. Magn. Reson. Med. 2004, 52, 1263-1271.
138. Coskun, P.E.; Beal, M.F.; Wallace, D.C. Alzheimer' s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. USA 2014, 101, 10726-10731.
139. Glenner, G.; Wong, C. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120, 885-890.
140. Karran, E.; Mercken, M.; de Strooper, B. The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 2011, 10, 698-712.
141. Swerdlow, R.; Khan, S. The Alzheimer's disease mitochondrial cascade hypothesis: An update. Exp. Neurol. 2009, 218, 308-315.
142. Napoli, C.; Palinski, W. Neurodegenerative diseases: Insights into pathogenic mechanisms from atherosclerosis. Neurobiol. Aging 2005, 26, 293-302.
143. Taylor, J.M.; Main, B.S.; Crack, P.J. Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease. Neurochem. Internatl. 2013, 62, 803-819.
144. Ahlskog, J.E. Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease. Mov. Disord. 2005, 20, 271-282.
145. Srinivasan, V.; Cardinali, D.P.; Srinivasan, U.S.; Kaur, C.; Brown, G.M.; Spence, D.W.; Hardeland, R.; Pandi-Perumal, S.R. Therapeutic potential of melatonin and its analogs in Parkinson's disease: Focus on sleep and neuroprotection. Ther. Adv. Neurol. Disord. 2011, 4, 297-317.
146. Bueler, H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. 2009, 218, 235-246.
147. Mangialasche, F.; Polidori, M.C.; Monastero, R.; Ercolani, S.; Camarda, C.; Cecchetti, R.; Mecocci, P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res. Rev. 2009, 8, 285-305.
148. Luckhaus, C.; Cohnen, M.; Fluss, M.O.; Janner, M.; Grass-Kapanke, B.; Teipel, S.J.; Grothe, M.; Hampel, H.; Peters, O.; Kornhuber, J.; et al. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res. 2010, 183, 44-51.
149. 1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol. Psychiatry 2004, 9, 705-710.
150. Hampel, H.; Burger, K.; Teipel, S.J.; Bokde, A.L.W.; Zetterberg, H.; Blennow, K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008, 4, 38-48.
151. Hampel, H.; Prvulovic, D.; Teipel, S.; Jessen, F.; Luckhaus, C.; Frolich, L.; Riepe, M.W.; Dodel, R.; Leyhe, T.; Bertram, L.; et al. The future of Alzheimer's disease: The next 10 years. Prog. Neurobiol. 2011, 95, 718-728.
152. Fox, J.H.; Connor, T.; Stiles, M.; Kama, J.; Lu, Z.; Dorsey, K.; Lieberman, G.; Sapp, E.; Cherny, R.A.; Banks, M.; et al. Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein. J. Biol. Chem. 2011, 286, 18320-18330.
153. Sorolla, M.A.; Rodriguez-Colman, M.J.; Tamarit, J.; Ortega, Z.; Lucas, J.J.; Ferrer, I.; Ros, J.; Cabiscol, E. Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic. Bio. Med. 2010, 49, 612-621.
154. Sorolla, M.A.; Rodriguez-Colman, M.J.; Vall-Llaura, N.; Tamarit, J.; Ros, J.; Cabiscol, E. Protein oxidation in Huntington disease. Biofactors 2012, 38, 173-185.
155. Barja, G. Endogenous oxidative stress: Relationship to aging, longevity and caloric restriction. Ageing Res. Rev. 2002, 1, 397-411.
156. Willcox, B.J.; Willcox, D.C.; Todoriki, H.; Fujiyoshi, A.; Yano, K.; He, Q.; Curb, J.D.; Suzuki, M. Caloric restriction, the traditional Okinawan diet, and healthy aging: The diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann. N. Y. Acad. Sci. 2007, 1114, 434-455.
157. Wolf, F.I.; Fasanella, S.; Tedesco, B.; Cavallini, G.; Donati, A.; Bergamini, E.; Cittadini, A. Peripheral lymphocyte 8-OHdG levels correlate with age-associated increase of tissue oxidative DNA damage in Sprague-Dawley rats. Protective effects of caloric restriction. Exp. Gerontol. 2005, 40, 181-188.
158. Contestabile, A. Benefits of caloric restriction on brain aging and related pathological States: Understanding mechanisms to devise novel therapies. Curr. Med. Chem. 2009, 16, 350-361.
159. Oien, D.B.; Osterhaus, G.L.; Lundquist, B.L.; Fowler, S.C.; Moskovitz, J. Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse. Neurosci. Lett. 2010, 468, 38-41.
160. Pamplona, R.; Barja, G. Mitochondrial oxidative stress, aging and caloric restriction: The protein and methionine connection. Biochim. Biophys. Acta 2006, 1757, 496-508.
161. Gillette-Guyonnet, S.; Vellas, B. Caloric restriction and brain function. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 686-692.
162. Ungvari, Z.; Parrado-Fernandez, C.; Csiszar, A.; de Cabo, R. Mechanisms underlying caloric restriction and lifespan regulation: Implications for vascular aging. Cardiocirc. Res. 2008, 102, 519-528.
163. Shinmura, K. Effects of caloric restriction on cardiac oxidative stress and mitochondrial bioenergetics: Potential role of cardiac sirtuins. Oxid. Med. Cell. Longev. 2013, doi:10.1155/2013/528935.
164. Halagappa, V.K.M.; Guo, Z.; Pearson, M.; Matsuoka, Y.; Cutler, R.G.; Laferla, F.M.; Mattson, M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 26, 212-220.